These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 8913922)
1. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922 [TBL] [Abstract][Full Text] [Related]
2. Effects of early steroid withdrawal after heart transplantation. Rosenbaum DH; Adams BC; Mitchell JD; Jessen ME; Paul MC; Kaiser PA; Pappas PA; Meyer DM; Wait MA; Drazner MH; Yancy CW; Ring WS; DiMaio JM Ann Thorac Surg; 2006 Aug; 82(2):637-44; discussion 644. PubMed ID: 16863778 [TBL] [Abstract][Full Text] [Related]
3. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up). Roberti I; Reisman L; Lieberman KV; Burrows L Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548 [TBL] [Abstract][Full Text] [Related]
4. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838 [TBL] [Abstract][Full Text] [Related]
5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
8. Factors associated with long-term survival following cardiac transplantation. Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228 [TBL] [Abstract][Full Text] [Related]
9. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158 [TBL] [Abstract][Full Text] [Related]
15. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
17. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]